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SYSTEMS FOR IMPLANTING AND USING A 
CONDUIT WITHIN A TISSUE WALL 
FIELD OF THE INVENTION 
This invention relates to devices and methods for creating, 
maintaining, controlling, and closing a fluid communication 
between opposing surfaces of a tissue wall. 
2 
BACKGROUND OF THE INVENTION 
In the human body, various organs contain fluids both in 
liquids and gaseous forms within tissue layers or cavities 
formed by tissue. These liquids may or may not be under 
pressure. The tissue walls around these cavities are normally 
designed to confine these liquids to specific areas of the body. 
Blood as in the heart and vasculature in order to preserve its 
volume and transport oxygen to tissue, gastric and intestinal 
fluids as in the stomach and intestines in order to transport 
remains of digestion out of the body after nutrients are 
absorbed, urine in the bladder in order to expel liquid waste 
from the body, fluid within the eye to maintain its shape and 
passage of light, are examples of such tissue fluid confining 
systems. During medical procedures within these cavities it is 25 
of extreme importance to control the fluid within. The most 
common example is cardiopulmonary bypass during open 
hearts surgery, although, in all procedures associated with the 
system above emphasis is placed on control of the fluid within 
the organ. For this control, sometimes extra space is required 30 
to conduct these interventions; therefore, highly invasive pro-
cedures may be required for surgery within these cavities, 
especially while maintaining organ function. The most com-
plex example of these being beating heart surgery. For less 
invasive procedures, especially those within the vascular sys- 35 
tern, access ports or conduits which allow for fluid commu-
nication, control and tissue closure within the organ being 
repaired are therefore required. 
Heart valve replacement is the most common open heart 
cardiovascular surgery procedure, currently most heart valve 
repair or replacement surgeries are conducted on a heart at 
rest under cardiopulmonary bypass through a large median 
sternotomy. This surgery is highly invasive, and therefore, the 
population that may survive such a procedure is limited to 
those who are strong surgical candidates. In recent years 
valves for minimally invasive deployment through the femo-
ral artery or apex of the heart have been developed. These 
10 
valves may be used in patients that would under other condi-
tions be deemed non-candidates. The use of these valves may 
also in the future reduce complications associated with car-
diopulmonary bypass and large incisions in surgical candi-
15 dates. For those procedures through the apex of the heart it has 
been shown that bleeding complications are directly associ-
ated with 50% increased mortality, therefore, and access con-
duit or port which would reduce bleeding complications, 
decrease incision size and simplify closure would be of great 
20 benefit. 
The various conduit and/port devices and systems 
described herein may be utilized as an accompaniment with 40 
any number of surgical procedures to gain access through a 
variety of possible tissues. For example, the conduit devices 
and systems may be utilized to provide fluid access across a 
tissue wall, such as, but not limited to, upon establishing an 
AAC, upon establishing a port for inter-ventricular repairs 45 
(e.g., valve repair, valve replacement, or ablation procedures, 
etc.), upon establishing valved and/or open conduits (includ-
ing bypass conduits) to augment native blood vessels in order 
to treat a variety of vascular conditions (e.g., aortic valvular 
disease, congestive heart failure, left ventricle outflow tract 50 
obstructions ("LVOTO"), peripheral arterial obstructions, 
small vessel obstructions, etc.), upon providing a conduit 
across a urinary bladder wall, upon providing a conduit across 
a gall bladder wall, upon providing a conduit into a thoracic 
cavity, upon providing a conduit into an abdominal cavity, 55 
upon providing a conduit into a cecal cavity, upon providing 
access into the cornea or eye walls, or upon providing access 
across or into any other tissue wall structures. Accordingly, 
the conduit devices and systems described herein may be 
utilized with any of the aforementioned procedures and/or to 60 
gain access through any of the aforementioned tissue walls. 
Because of the importance of heart function and the com-
plexities associated to this pressurized system, some of the 
most complex procedures associated with bodily fluids are 
performed on this organ. Several of these procedures would 65 
benefit from a conduit or port which can maintain a fluid tight 
seal with tissue surfaces. 
Another procedure that would benefit from a fluid tight 
conduit or port into the heart would be the construction of an 
alternative conduit between the left ventricle and the aorta (an 
apicoaortic conduit, or AAC). This procedure creates a 
double-outlet left ventricle (LV) to treat a variety of complex 
congenital LV outflow obstruction (fibrous t=el obstruc-
tion, aortic annular hypoplasia, tubular hypoplasia of the 
ascending aorta, and patients with diffuse septa! thickening, 
severe LV hypertrophy and a small LV cavity) as well as 
adult-onset aortic stenosis in patients with complicating pre-
operative conditions (previous failed annular augmentation 
procedures, previous infection, previous CABG with patent 
anterior internal mammary artery grafts, and a porcelain 
ascending aorta). However, the AAC insertion procedure has 
been poorly accepted, with or without cardiopulmonary 
bypass, has not been as technically straightforward as direct 
aortic valve replacement. Nonetheless, several studies have 
demonstrated that AAC insertion successfully lessens the 
LY-aortic pressure gradient, preserves or improves ventricu-
lar function and maintains normally distributed blood flow 
through the systemic and coronary circulation. 
While there have been several techniques described, the 
most commonly employed method is the lateral thoracotomy 
approach with placement of the AAC to the descending aorta 
or a median sternotomy. The current techniques and technol-
ogy available to perform AAC insertion were originally 
designed to be performed on-pump; either with an arrested or 
fibrillating heart, therefore, highly invasive. While off-pump 
cases have been described, they can be technically difficult 
due to the shortcomings of presently available conduits and 
systems for installing such conduits. For example, because 
existing conduits require the use of sutures to reliably secure 
the connector in place, it is often difficult for surgeons or other 
clinicians to insert such sutures reliably in active cardiac 
and/or vascular tissue. 
Some devices and methods have been devised to install an 
AAC conduit, such as those described generally in U.S. 
Patent Publication No. 2006/0089707 which is hereby incor-
porated by reference herein in its entirety. However, these 
AAC conduit devices and installation systems rely on the use 
of a flexible flange that is inserted through a pre-defined 
aperture in the ventricular apex. Thus, such methods require 
the use of a haemostatic device (such as an occlusion balloon 
and/or "umbrella" device) to prevent blood loss from the 
aperture during installation of the AAC conduit. Other apical 
conduit devices are described in U.S. Pat. No. 7,846,123, 
which is also hereby incorporated by reference in its entirety. 
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Accordingly, improved beating heart fluid tight conduits 
for heart surgery as such described herein, are desirable. 
SUMMARY OF THE INVENTION 
4 
Various embodiments of the present invention provide an 
improved system and method for the insertion of a conduit 
connector or port (such as anAAC conduit) that will signifi-
cantly simplify the in vivo beating heart treatment of cardiac 
patients. The connector, port or conduit may be inserted into 
the beating cardiac apex or other tissue walls (such as other 
areas of the heart including the anterior, lateral, posterior 
walls of the left or right ventricle, the left or right atrium, the 
aortic wall, ascending, transverse, or descending, or other 
blood vessel walls), such that it may effectively reduce and/or 15 
negate the detrimental effects of both cardio-pulmonary by-
pass (CPB) and global cardiac ischemia. Additionally, 
embodiments of such conduits that may be capped as ports 
and may be used as an access site for intravascular and intra-
cardiac procedures such as valve repair or replacement. Vari- 20 
ous embodiments of the present invention may also provide 
general conduit devices (and systems for implanting) suitable 
for establishing fluid communication between opposing sur-
faces of tissue walls in a variety of applications, including the 
establishment of a fluid conduit through the tissue wall of a 25 
mammalian stomach or urinary bladder. 
defined by the outer tube. According to such embodiments, 
the inner tube defines a conduit aperture extending axially 
therethrough. Furthermore, in some such embodiments, the 
outer tube may comprise a first securing device operably 
engaged with a proximal end of the outer tube and the inner 
tube may comprise a complementary second securing device 
operably engaged with a proximal end of said inner tube. 
Thus, according to such embodiments, the second securing 
device may be configured for selectively operably engaging 
10 the first securing device so as to operably engage the inner 
tube with the outer tube to install and maintain the conduit. 
In one exemplary embodiment, a system is provided for 
implanting a conduit device in a tissue wall having a first 
surface and an opposing second surface. According to some 
embodiments, the system comprises an outer tube defining a 30 
guide aperture extending axially through the outer tube and an 
attaching device extending from a distal end of said outer 
tube. The attaching device is configured for advancing along 
a helical path at least partially through the tissue wall such 
that at least a portion of the attaching device becomes dis- 35 
posed substantially between the first surface and the opposing 
second surface of the tissue wall when the outer tube is rotated 
relative to the first surface of the tissue wall. The attaching 
device, in some system embodiments, comprises at least one 
In some embodiments, the system may also comprise a 
coring or piercing device configured for advancing through 
the conduit aperture defined by the inner tube and through the 
tissue wall to define an aperture therein. The coring or pierc-
ing device may be further configured for carrying the inner 
tube through the aperture such that the inner tube extends at 
least partially through the aperture so as to establish fluid 
communication between the first and second surfaces of the 
tissue wall. In the embodiments associated with attaching 
devices including radially expanding helices, inward com-
pression of the tissue will form a sealing surface against the 
outer surface in the inner tube. 
Various other embodiments of the present invention pro-
vide a conduit system including an outer lumen, an inner 
lumen, and an attaching device. In other embodiments, a 
multiple access port device adapted for communication with 
at least one of an outer lumen, an inner lumen, or an attaching 
device of a conduit system is provided. In yet other embodi-
ments, a system including an inner lumen that is collapsible is 
provided. Means for closing a conduit system are also pro-
vided, including a plug for insertion through an attaching 
device and a variable radius coiled member associated with 
an attaching device. 
Various other embodiments of the present invention 
include an outer lumen configured for extension and contrac-
tion, as well as universal motion absorption. Further embodi-
40 ments include an outer lumen comprising a collapsible dia-
phragm. Still further embodiments comprise expandable 
delivery systems for endovascular and percutaneous applica-
tions. 
of a helical static coil and a helical elastic spring having a 
sharpened distal end adapted for piercing the tissue wall as the 
outer tube is rotated relative to the first surface of the tissue 
wall. According to some such embodiments, the attaching 
device may define a radially-expanding helix as the attaching 
device extends away from the distal end of the outer tube. In 45 
such configuration the insertion of the radially expanding 
helix within the tissue will create inward pressure or contrac-
tion of said tissue within the circumference of the coil. 
In some embodiments, the system also comprises a ring or 
flange operably engaged about an outer surface of the outer 
tube and configured for cooperating with the attaching device 
such that at least a portion of the tissue wall is secured 
between the attaching device and the ring so as to operably 
engage said outer tube with the tissue wall. In some embodi-
ments, various system components, such as the outer tube and 
the ring, may be configured to conform to and/or establish a 
substantially fluid-tight seal with at least a portion a surface of 
the tissue wall. In some embodiments, the system may be 
configured to cooperate and/or operably engage a tissue wall 
comprising a substantially curved tissue wall. According to 
some such embodiments, the ring may comprise a frusto-
conical assembly or flange configured for receiving at least a 
portion of the substantially curved tissue wall so as to form a 
substantially fluid-tight seal between the frusto-conical 
assembly and the tissue wall. 
In some embodiments, the system further comprises an 
inner tube configured for insertion into the guide aperture 
The various embodiments of the present invention may 
thus be configured for implanting a conduit device that is 
adapted for providing a conduit for a medical procedure. Such 
procedures may include, but are not limited to: bypass; car-
diac valve repair or replacement; attachment of a ventricular 
assist device; establishment of an apicoaortic conduit (AAC) 
50 and combinations of such procedures. 
Use of this new conduit device, system, and method will 
significantly improve the ease and safety of conduit insertion 
(such as the implantation of AAC devices, for example). For 
55 
example, various embodiments of the present invention may 
allow the outer tube to be securely operably engaged with the 
tissue wall (due at least in part to the cooperation of the 
attaching device and the ring) prior to the removal of a tissue 
core to define an aperture in the tissue wall. Thus, portions of 
60 the system disclosed herein may define a guide aperture 
extending axially through the outer tube for receiving a coring 
device that may be configured to be capable of efficiently 
removing and retrieving a tissue core while substantially 
simultaneously operably engaging a inner tube in the guide 
65 aperture so as to establish fluid communication between first 
and second opposing surfaces of the tissue wall. As persons of 
ordinary skill in the art will readily appreciate, the various 
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embodiments of the present invention may also be used in a 
minimally invasive, endoscopically assisted approach. 
BRIEF DESCRIPTION OF THE DRAWINGS 
Having thus described various embodiments of the inven-
tion in general terms, reference will now be made to the 
accompanying drawings, which are not necessarily drawn to 
scale, and wherein: 
FIG. 1 shows a non-limiting perspective view of an exem-
plary system for implanting a conduit device, according to 
one embodiment of the present invention. 
10 
6 
tissue core removed from the tissue wall by the coring device, 
according to one embodiment of the present invention. 
FIG. 6 shows a non-limiting side view of an exemplary 
coring device carrying an inner tube configured for insertion 
into a guide aperture defined by the outer tube, according to 
one embodiment of the present invention. 
FIG. 7 shows a non-limiting perspective view of an exem-
plary conduit device comprising an attaching device compris-
ing a helical spring, according to one embodiment of the 
present invention. 
FIG. 8 shows a non-limiting cross-sectional view of an 
exemplary outer lumen for use with conduit systems 
described herein, according to one embodiment of the present 
FIG. 2 shows a non-limiting side cross-sectional view of an 
exemplary system for implanting a conduit device, according 
to one embodiment of the present invention. 15 invention. 
FIG. 3 shows a non-limiting side cross-sectional view of an 
exemplary conduit device implanted in a tissue wall, accord-
ing to one embodiment of the present invention. 
FIG. 4 shows a non-limiting side view of an exemplary 
system for implanting a conduit device, according to one 20 
embodiment of the present invention. 
FI GS. SA-SG show an exemplary set of views of the instal-
lation of a conduit device using an exemplary system, accord-
ing to one embodiment of the present invention. 
FIG. 9 shows a non-limiting cross-sectional view of an 
exemplary inner lumen for use with conduit systems 
described herein, according to one embodiment of the present 
invention. 
FIG. 10 shows a non-limiting cross-sectional view of an 
exemplary inner lumen inserted within an outer lumen for use 
with conduit systems described herein, according to one 
embodiment of the present invention. 
FIG. 11 shows a non-limiting perspective view ofan exem-
plary inner lumen inserted within an outer lumen for use with 
conduit systems described herein, according to one embodi-
ment of the present invention. 
FIG. SA shows a non-limiting side cross-sectional view of 25 
an exemplary system for implanting a conduit device com-
prising an attaching device at least partially implanted in a 
tissue wall, according to one embodiment of the present 
invention. 
FIG.12 shows a non-limiting perspective view ofan exem-
plary attaching device for use with conduit systems described 
30 herein, according to one embodiment of the present inven-FIG. SB shows a non-limiting side cross-sectional view of 
an exemplary system for implanting a conduit device com-
prising an attaching device and a ring cooperating to secure at 
least a portion of the tissue wall between the attaching device 
and the ring so as to operably engage said outer tube with the 
tissue wall, according to one embodiment of the present 
invention. 
ti on. 
FIGS. 13A-13C illustrate a cross-sectional view of an 
example delivery system, in accordance with one embodi-
35 ment of the invention with a motion absorption element. 
FIG. SC shows a non-limiting side cross-sectional view of 
an exemplary system for implanting a conduit device com-
prising a coring device carrying an inner tube configured for 
insertion into a guide aperture defined by the outer tube, 40 
wherein the coring device is advanced at least partially 
through the tissue wall so as to remove a tissue core thereof, 
according to one embodiment of the present invention. 
FIG. SD shows a non-limiting side cross-sectional view of 
FIGS. 14A-14B illustrate a cross-sectional view and FIG. 
14C illustrates anend view of a type of valve that is a rotation 
collapsible diaphragm valve, consisting of two or more con-
duits connected by a flexible conduit, in accordance with one 
embodiment of the invention. 
FIG. lS shows an exemplary embodiment of an inner tube 
constituted by a sheath with a duckbilled valve and a collaps-
ible valve in its proximal end. 
FIG. 16 shows an exemplary embodiment of an inner tube 
constituted by a sheath with a duckbilled valve and a collaps-
ible valve in its proximal end. A dilator is placed within the 
lumen of the sheath in order to facilitate access into the tissue. 
an exemplary system for implanting a conduit device com- 45 
prising a coring device carrying an inner tube configured for 
insertion into a guide aperture defined by the outer tube, 
wherein the coring bore defined by the coring device contains FIGS. 17A-17F show non-limiting cross-sectional views 
of an exemplary method for using a conduit system described 
50 herein, according to one embodiment of the present inven-
tion. 
a tissue core removed from the tissue wall, according to one 
embodiment of the present invention. 
FIG. SE shows a non-limiting side cross-sectional view of 
an exemplary system for implanting a conduit device com-
prising a coring device carrying an inner tube configured for 
insertion into a guide aperture defined by the outer tube, 
wherein a piercing rod is retracted through the coring bore 55 
after removal of the tissue core such that the tissue core is 
retrievable via a proximal end of the coring device, according 
to one embodiment of the present invention. 
FIG. SF shows a non-limiting side cross-sectional view of 
FIGS. 18A-18B illustrate perspective and cross-sectional 
views of a delivery system in accordance with one embodi-
ment of the invention. 
FIGS. 19A-19L illustrate the primary steps of an over-wire 
procedure that can benefit from using the various components 
described herein. 
an exemplary system for implanting a conduit device, 60 
wherein the outer tube and innertube are installed in the tissue 
FIG. 20 shows a non-limiting perspective view ofan exem-
plary multiple access port device for use with conduit systems 
described herein, according to one embodiment of the present 
invention. wall so as to establish fluid communication between the first 
and second surfaces of the tissue wall, according to one 
embodiment of the present invention. 
FIG. SG shows a non-limiting side cross-sectional view of 
an exemplary coring device, wherein a handle operably 
engaged with a proximal end of the coring device contains a 
FIG. 21A illustrates a cross-sectional view of an example 
delivery system having a lumen with a steerable tip, in accor-
65 dance with one embodiment of the invention. FIG. 21B. Illus-
trates diagrams of an example lumen with a steerable tip, in 
accordance with one embodiment of the invention. 
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FIGS. 22A-22D show non-limiting perspective views ofan 
exemplary collapsible inner lumen for use with conduit sys-
tems described herein, according to one embodiment of the 
present invention. 
FIGS. 23A-23C show non-limiting perspective views of 
exemplary collapsible inner lumens for use with conduit sys-
tems described herein, according to embodiments of the 
present invention. 
FI GS. 24A-24 B show non-limiting perspective views ofan 
exemplary collapsible inner lumen having a flexible tip for 
use with conduit systems described herein, according to one 
embodiment of the present invention. 
FI GS. 25A-25B show non-limiting perspective views ofan 
exemplary plug for use with an attaching device described 
herein, according to one embodiment of the present inven-
tion. 
FI GS. 26A-26B show non-limiting perspective views ofan 
exemplary plug for use with an attaching device described 
herein, according to one embodiment of the present inven-
tion. 
FI GS. 27 A-27B show non-limiting perspective views ofan 
exemplary delivery instrument for securing a plug to an 
attaching device described herein, according to one embodi-
ment of the present invention. 
FI GS. 28A-28B show non-limiting perspective views ofan 
exemplary variable radius coiled member for use with an 
attaching device described herein, according to one embodi-
ment of the present invention. 
FI GS. 29 A-29B show non-limiting perspective views ofan 
exemplary attaching device including pledgets and sutures 
for use with conduit systems described herein, according to 
one embodiment of the present invention. 
DETAILED DESCRIPTION OF THE INVENTION 
8 
conduit comprising: a medical instrument; a flow control 
diaphragm valve sized and shaped for receiving the medical 
instrument therethrough, comprising a first rigid conduit hav-
ing proximal and distal ends, a flexible conduit attached in 
fluid communication at a distal end of the first rigid conduit, 
and a second rigid conduit attached in fluid communication at 
a distal end of the flexible conduit; wherein twisting rotation 
of the first rigid conduit relative to the second rigid conduit 
causes the flexible conduit to collapse inward and selectively 
10 move from an open configuration to a closed configuration 
forming a fluid-tight seal around the medical instrument 
when inserted therein or forming a fluid-tight closing when 
the medical instrument is not inserted therein. In certain 
embodiments, the valve further comprises a locking element 
15 to maintain the valve in the closed configuration. In certain 
embodiments, the system further comprises an insertion 
sheath connected to the flow control diaphragm valve. 
In certain embodiments, the invention provides a system 
wherein the outer lumen comprises a selectively extendible 
20 section to lengthen or shorten the outer lumen. In certain 
embodiments, the outer lumen comprises telescopically 
extendible segments. In certain embodiments, the inner 
lumen is radially expandable in longitudinal cross-section. In 
certain embodiments, the inner lumen is collapsible and com-
25 prises an expanding member and a membrane over an outer 
surface of the expanding member. In certain embodiments, 
the inner lumen comprises a medical inserter sheath mounted 
on a dilator. In certain embodiments, the expandable member 
is expanded using at least one of: (a) mechanical force; (b) 
30 material modification; (c) structure modification; (d) electri-
cal energy; or ( e) thermal energy. In certain embodiments, the 
collapsible inner lumen comprises a flexible tip configured to 
allow selective sealing of the inner lumen. 
The invention also provides a system for using a conduit 
35 device through a tissue wall of a patient, comprising: an outer 
lumen; an inner lumen adapted for insertion at least partially 
through the outer lumen; an attaching device in communica-
tion with a distal end of one of the outer lumen or the inner 
The present inventions now will be described more fully 
hereinafter with reference to the accompanying drawings, in 
which some, but not all embodiments of the inventions are 
shown. Indeed, these inventions may be embodied in many 
different forms and should not be construed as limited to the 40 
lumen, wherein the attaching device is adapted for securing to 
or inserting at least partially through a tissue wall, and in 
particular a cardiovascular apical cavity, wherein the outer embodiments set forth herein; rather, these embodiments are 
provided so that this disclosure will satisfy applicable legal 
requirements. Like numbers refer to like elements through-
out. The singular forms "a," "an," and "the" include plural 
referents unless the context clearly dictates otherwise. 
Certain embodiments of the invention provide devices, 
methods and systems for using a conduit device through a 
tissue wall of a patient, comprising: an outer conduit lumen; 
an inner conduit lumen adapted for insertion at least partially 
through the outer lumen; an attaching device in communica-
tion with a distal end of one of the outer lumen or the inner 
lumen, wherein the attaching device is adapted for securing to 
or inserting at least partially through a tissue wall, and a flow 
control mechanism configured to permit the passage of medi-
lumen comprises a motion absorbing element to permit rela-
tive movement between the attaching device and the outer 
lumen. In certain embodiments, the motion absorbing ele-
45 ment is a portion of the conduit configured as a flexible 
accordion segment or as two conduit segments connected by 
a universal ball joint. 
In certain embodiments, the invention provides a system 
for using a conduit device through a tissue wall of a patient, 
50 particularly a cardiovascular apical cavity, comprising: an 
outer lumen; an inner lumen adapted for insertion at least 
partially through the outer lumen; an attaching device in 
communication with a distal end of one of the outer lumen or 
cal instruments therethrough. In certain embodiments, the 55 
outer lumen comprises one or more flow control mechanisms. 
the inner lumen, wherein the attaching device is adapted for 
securing to or inserting at least partially through a tissue wall, 
wherein the inner lumen further comprises a steerable tip 
In certain embodiments, the inner lumen comprises one or 
more flow control mechanisms. 
comprising a guiding tip movably mounted on a distal end of 
the inner lumen, wherein the tip can be guided by the user in 
at least two dimensions. 
In certain embodiments, the guiding tip comprises a ring 
guide mounted on a curved deflector element, and wherein 
said curved deflector element is movable over a range 
between a proximal straightened position and a distal increas-
ingly deflected position, such that movement to the distal 
The invention provides further embodiments, wherein the 
attaching device is adapted for releasably attaching to the 60 
outer lumen. In certain embodiments, a multiple access port 
device is provided in communication with at least one of the 
outer lumen or the inner lumen, wherein the multiple access 
port device includes a plurality of individual ports in fluid 
communication with the outer lumen or the inner lumen. 65 deflected position causes a guide wire extending through the 
inner lumen and through the ring guide to be directed toward 
the deflected position. In using such a device, the operator can 
In certain embodiments, the invention provides a system 
for fluid sealed passage of a medical instrument through a 
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achieve two or three-dimensional steering by distally and 
proximally manipulating the deflector element, in combina-
tion with rotating the inner lumen and/or axially moving the 
inner lumen distally or proximally. 
The present invention further provides a system for using a 
conduit device through a tissue wall of a patient, comprising: 
an outer lumen; an inner lumen adapted for insertion at least 
partially through the outer lumen; an attaching device in 
communication with a distal end of one of the outer lumen or 
10 
haemostatic device. In certain embodiments, the collapsible 
inner lumen comprises an expanding member and a mem-
brane over the outer surface of the expanding member. In 
certain embodiments, the collapsible inner lumen is adapted 
for insertion through a trans-cutaneous or endovascular 
access system when in a collapsed state. In certain embodi-
ments, the collapsible inner lumen is adapted for receiving at 
least one medical instrument therethrough when in an 
expanded state. 
In certain embodiments the invention provides a device for 
closing a conduit system, comprising: an attaching device 
adapted for securing to or inserting at least partially through 
a tissue wall, wherein the attaching device has a passage 
defined therethrough to allow fluid communication through 
the inner lumen, wherein the attaching device is adapted for 10 
securing to or inserting at least partially through a tissue wall, 
wherein the attaching device further comprises a plug adapted 
for insertion through the attaching device to substantially seal 
the attaching device and prevent fluid flow through the attach-
ing device, wherein the plug further comprises an extended 
surface extending distally from the plug, wherein the 
extended surface is adapted for insertion through a puncture 
15 the attaching device; and a plug adapted for insertion into the 
passage of the attaching device to substantially seal the 
attaching device and prevent fluid flow through the attaching 
device. in the tissue wall. 
In certain embodiments, the plug has a flexibly sealable 
distal tip for selective access to the tissue from within the 20 
inner lumen. In certain embodiments, the attaching device 
further comprises means for exerting an inward radial force 
against the tissue, wherein, when the attaching device is 
implanted, the inward radial force urges the tissue inward 
toward the extended surface of the plug. In certain embodi- 25 
ments, the means for exerting an inward radial force com-
prises at least one of: (a) a radially expanding coil; (b) a 
conical flange: (c) one or more arm or barb members. In 
certain embodiments, the plug further comprises radial 
threads that engage corresponding radial threads on the 30 
attaching device to seal the tissue wall. 
In certain embodiments, the invention provides systems 
and methods for delivering a medical instrument through a 
cardiovascular apical cavity tissue wall of a patient compris-
ing: a) securing an attaching device to the cardiovascular 
apical cavity tissue wall, wherein the attaching device is 
adapted for securing a blood flow control mechanism config-
ured to sealably permit the passage of medical instruments 
therethrough; b) puncturing the tissue wall; and c) dilating the 
punctured tissue for delivery of the medical instrument there-
through; wherein steps a) and b) may be performed in any 
order. 
These and many other embodiments of the invention will 
be readily apparent to one of skill in the art in view of the 
present disclosure. Although some embodiments of the 
invention described herein are directed to a conduit device 
(see FIGS. 1 and 7, for example) and a system for implanting 
such a device to form an apicoaortic connector (AAC) 
between the cardiac apex and the aorta, for example, it will be 
In certain embodiments of the invention, the attaching 
device further comprises a variable radius coiled member 
adapted to exist in a relaxed state having a narrow section with 
an inner diameter less than other sections of the variable 35 
radius coiled member, wherein when changing from an 
expanded state to a relaxed state, the narrow section diameter 
decreases, and wherein, when the attaching device is 
implanted, decreasing the narrow section diameter urges the 
tissue in an inward radial direction. In certain embodiments, 
changing from the expanded state to the relaxed state results 
from removing a plug from the attaching device, wherein 
prior to removal the plug exerts an outward radial force on the 
narrow section expanding the diameter of the narrow section. 
In certain embodiments, the invention provides a system 
for providing access to a cardiovascular apical cavity com-
prising an attaching device adapted for securing to or insert-
ing at least partially through a cardiovascular apical tissue 
wall, and at least one suture disposed on the device, wherein 
upon release of the attaching device from the tissue wall, the 
at least one suture is utilized to facilitate closing of the tissue 
wall. In certain embodiments, the attaching device uses a 
helical path when attaching to the securing tissue In certain 
embodiments, the attaching device further comprises at least 
one pledget in communication with the at least one suture, 
wherein, during removal of the attaching device from the 
tissue wall, the at least one pledget and the at least one suture 
are utilized to facilitate closing of the tissue wall. 
In certain embodiments, the invention provides a system 
for using a conduit device through a tissue wall of a cardio-
vascular apical cavity of a patient, comprising: an inner lumen 
adapted for at least partial insertion through the tissue wall of 
the patient and providing fluid communication therebetween, 
wherein the inner lumen is a collapsible inner lumen. In 
certain embodiments, the system comprises a flow control 
mechanism configured to permit the passage of medical 
instruments therethrough, and does not require the use of a 
appreciated by one skilled in the art that the invention is not so 
limited. For example, aspects of the conduit device and sys-
tems of the present invention can also be used to establish 
40 and/or maintain conduits in a variety of tissue structures using 
minimally-invasive and/or invasive delivery techniques. Fur-
thermore, while certain embodiments of the invention 
described herein are directed to the thoracoscopic implanta-
tion of the conduit device to form at least one port for estab-
45 lishing an AAC, it should be understood that the system 
and/or vascular conduit device embodiments of the present 
invention may be used to establish valved and/or open con-
duits (including bypass conduits) to augment native blood 
vessels in order to treat a variety of vascular conditions 
50 including, but not limited to: aortic valvular disease, conges-
tive heart failure, left ventricle outflow tract obstructions 
(LVOTO), peripheral arterial obstructions, small vessel 
obstructions, electrical abnormalities within the heart, con-
genital defects within the heart, failure or aneurisms in sur-
55 rounding vessels, occlusion or thrombosis in coronaries or 
other arteries, and/or other conditions. Furthermore, the vas-
cular conduit device and system of the present invention may 
also be used to establish a port for inter-ventricular repairs 
such as, for example, valve repair and/or replacement or 
60 ablation procedures. Thus, the conduit device described in 
further detail below may also comprise a threaded fluid-tight 
cap, and/or a cap having at least one pawl member (for engag-
ing corresponding ridges defined on an outer surface of the 
conduit device) for selectively sealing a proximal end of the 
65 conduit device such that the inner tube thereof may serve as a 
re-usable port for repairing and/or treating diseased portions 
of the cardiac anatomy. Furthermore, the conduit device and 
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system embodiments of the present invention may also be 
used to implant a conduit and/or port for left ventricular assist 
devices. 
It should be further understood that various embodiments 
of the conduit device described herein may also be utilized to 
establish fluid communication between opposing surfaces of 
a variety of tissue walls and/or anatomical structures. For 
example, in some embodiments, the conduit device and sys-
tem for implanting described herein may be used to establish 
a conduit (and consequently fluid communication) between 10 
opposing surfaces of a wall of an anatomical structure that 
may include, but is not limited to: a urinary bladder; a gall 
bladder; a diaphragm; a thoracic cavity; an abdominal cavity; 
12 
The attaching device lS may comprise, in some embodi-
ments, a helical static coil having a sharpened distal end 
adapted for piercing the tissue wall 8SO as the outer tube 10 is 
rotated relative to the first surface 8SS of the tissue wall 8SO. 
In other embodiments, the attaching device lS may comprise 
a helical elastic spring having a sharpened end adapted for 
piercing the tissue wall 8SO as the outer tube 10 is rotated 
relative to the first surface 8SS of the tissue wall 8SO. In some 
embodiments, as shown in FIG. 4, wherein the attaching 
device lS comprises a helical spring and/or coil, the spring 
and/or coil may device a radially-expanding helix as the 
attaching device lS extends away from the distal end of the 
outer tube 10. In some embodiments, wherein the attaching 
device comprises a conical and/or "radially-expanding" an intestinal structure; a cecal cavity; and other tissue wall 
structures. 
It should be understood that the various conduit device 
components described herein (see, for example, the compo-
nents shown generally throughout FIGS. 1-S) may comprise 
a variety of biocompatible materials including, but not lim-
ited to: stainless steel; titanium substantially rigid biocom-
patible polymers; elastomeric biocompatible polymers; and 
combinations of such materials. For example, in some 
embodiments, the outer tube 10, ring 30, nut 20, and inner 
tube 40 may comprise substantially rigid biocompatible poly-
mers. In some embodiments, the attaching device lS may 
comprise a biocompatible metal and/or metal alloy that may 
15 helix, the attaching device lS may act to compress at least a 
portion of the tissue wall 8SO radially inward and towards an 
outer surface of the innertube 40 so as to establish a substan-
tially fluid-tight seal between the outer surface of the inner 
tube 40 and the portion of the tissue wall 8SO that has been 
20 urged radially inward. Furthermore, in some such embodi-
ments, the radially-expanding helix of the attaching device lS 
may correspond, for example, to a ring 30 comprising a 
frusto-conical assembly configured for receiving at least a 
portion of a substantially curved tissue wall 8SO (see, for 
25 example, FIG. SB) so as to forma substantially fluid-tight seal 
between the frusto-conical assembly of the ring 30 and the 
tissue wall 8SO. be embedded substantially within and/or operably engaged 
with an injection-molded polymer used to form the outer tube 
10. Furthermore, as described further herein, some embodi-
ments of the present invention may further comprise a sealing 30 
member 3S operably engaged with a distal end of the ring 30. 
In such embodiments, the sealing member 3S may comprise 
a substantially compliant biocompatible polymer (such as an 
elastomeric polymer) that may be suitable for establishing a 
substantially fluid tight seal between the ring 30 a surface of 35 
the tissue wall 8SO. Similarly, the various components of the 
coring device 2 described herein may also comprise a com-
bination of biocompatible materials suitable for removing 
and retaining the tissue core 8SOa in order to define an aper-
ture in the tissue wall 8SO such that the inner tube 40 may be 40 
installed to establish fluid communication between the 
opposing first and second surfaces 8SS, 8S3 of the tissue wall 
8SO (as shown in FIG. SA, for example). 
As shown generally in FIGS. 1-3, one embodiment of a 
system for implanting a conduit device 1 in a tissue wall 8SO 45 
having a first surface 8SS and an opposing second surface 8S3 
may comprise an outer tube 10 defining a guide aperture 
extending axially therethrough and an attaching device lS 
extending from a distal end of the outer tube 10. The attaching 
device lS may be configured for advancing along a helical 50 
path at least partially through the tissue wall 8SO such that at 
least a portion of the attaching device lS becomes disposed 
substantially between the first surface 8SS and the opposing 
second surface 8S3 of the tissue wall 8SO when the outer tube 
10 is rotated relative to the first surface 8SS of the tissue wall 55 
In other embodiments, as shown generally in FIG. 7, the 
attaching device lS may comprise a helical spring and/or coil 
having a substantially constant helical diameter as the attach-
ing device lS extends away from the distal end of the outer 
tube 10. The substantially consistent helical diameter of the 
attaching device lS shown generally in FIG. 7 may be useful 
for operably engaging the outer tube 10 with a substantially 
flat tissue wall. Furthermore, as shown generally in FIG. 7, in 
some embodiments, the corresponding ring 30 (and the cor-
responding sealing member 3S that may be operably engaged 
therewith) may also be configured to provide a substantially 
flat and/or disc-shaped sealing surface that may be suitable 
for seating on and/or establishing a substantially fluid-tight 
seal with a substantially flat first tissue surface that may 
surround an aperture defined in a correspondingly flat tissue 
wall. 
As described herein, the system may further comprise a 
ring 30 operably engaged about an outer surface of the outer 
tube 10. As shown generally in FIGS. 3 and SB, the ring 30 
may be configured for cooperating with the attaching device 
lS such that at least a portion of the tissue wall 8SO is secured 
between the attaching device lS and the ring 30 so as to 
operably engage the outer tube 10 with the tissue wall 8SO. 
Some embodiments may further comprise a plurality of 
ridges 11 and/or threads disposed on the outer surface of the 
outer tube 10. According to such embodiments, the ring 30 
may comprise at least one deformable pawl member config-
ured for releasably engaging the plurality of ridges 11 dis-
posed on the outer surface of the outer tube 10. Other embodi-
ments (as shown generally in FIG. 2, for example), may also 
further comprise threading 11 on at least a portion of the 
outside surface of the outer tube 10 and corresponding thread-
8SO. As shown generally in FIG. 2, the attaching device lS 
may be integrally formed within the outer tube 10. For 
example, the attaching device lS may, in some embodiments, 
be placed at least partially in a mold such that the polymeric 
or other components of the outer tube 10 may be molded 
substantially around at least a portion of the attaching device 
lS (which may comprise a static coil and/or elastic spring, as 
described further herein). In other embodiments, the attach-
ing device lS may be operably engaged with at least a portion 
of the outer tube 10 via adhesive, RF welding, and/or other 
attachment methods that may be suitable for securely oper-
ably engaging the attaching device lS to the outer tube 10. 
60 ing on at least a portion of an inside surface of the ring 30. The 
threading 11 (and corresponding threading on the inner sur-
face of the ring 30) may be being configured to cooperate for 
axially securing the ring 30 relative to the outer tube 10. 
As shown generally in FIGS. SA-SB, some embodiments 
65 may further comprise a nut 20 operably engaged about an 
outer surface of the outer tube 10 and proximal to the ring 30. 
According to such embodiments, the nut 20 may comprise 
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threading on at least a portion on an inside surface of the nut 
20. The threading disposed on the inside surface of the nut 20 
may be configured for cooperating with the threading 11 on at 
least a portion of the outside surface of the outer tube 11 for 
axially securing the nut 20 relative to the outer tube 10 and the 5 
adjacent ring 20. As shown in FI GS. SA-SB, the nut 20 may be 
configured for cooperating with the ring 30 to advance the 
ring 30 towards the distal end of the outer tube 10. As shown 
generally in FIGS. SA-SB, the attaching device lS may pro-
vide counter-traction so as to allow for the rotation (and 10 
resulting advancement) of the nut 20 (and the ring 30 dis-
posed distally thereto) such that rotation of the nut 20 (and the 
corresponding movement of the ring 30 toward the first tissue 
surface 8SS) may draw at least a portion of the tissue wall 8SO 
into engagement with an inner surface of the ring 30 such that 15 
the conduit device 1 (and particularly the outer tube 10 
thereof) is stabilized, engaged in a substantially fluid tight 
seal, and/or operably engaged with respect to the tissue wall 
8SO prior to the use of a coring device 2 for removing a tissue 
core 8SOa via the guide aperture defined axially through the 20 
outer tube 10, as shown in FIGS. SC and SD. 
In order to ensure that the ring 30 forms a substantially 
fluid-tight seal with the first surface 8SS of the tissue wall 8SO 
about the aperture defined therein, some embodiments (as 
shown in FIG. 1, for example) may further comprise a sealing 25 
member 3S operably engaged with a distal end of the ring 30. 
The sealing member 3S may comprise, for example, a gasket 
or other elastomeric component configured for establishing a 
substantially fluid tight seal between the ring 30 and the first 
surface 8SS of the tissue wall 8SS. As described herein, some 30 
embodiments of the present invention may be configured for 
establishing fluid communication between the opposing sides 
of the walls of a manmialian heart (such as the ventricular 
apex, for example). In such embodiments, the conduit device 
1 may be required to be operably engaged with a substantially 35 
curved tissue wall 8SO (see FIG. SA, for example). In such 
embodiments, the ring 30 may comprise a frusto-conical 
assembly configured for receiving at least a portion of the 
substantially curved tissue wall 8SO so as to form a substan-
tially fluid-tight seal between the frusto-conical assembly of 40 
the ring 30 and the tissue wall 8SO. 
As shown, for example, in FIG. SB, in some embodiments, 
the ring 30 may be urged towards a distal end of the outer tube 
10 by the rotation of a nut 20 about threading 11 disposed on 
an outer surface of the outer tube 10. Thus, according to some 45 
such embodiments, the cooperation of the attaching device lS 
(which may comprise a piercing helical spring and/or coil, for 
example) with the ring 30 may act to draw at least a portion of 
the curved tissue wall 8SO into the frusto-conical assembly of 
the ring 30 such that a substantially fluid-tight seal may be 50 
formed and maintained between the frusto-conical assembly 
of the ring 30 and the tissue wall 8SO. 
In some conduit device 1 embodiments, as shown gener-
ally in FIG. 2, thering 30 may comprise a seal testing aperture 
36 that may allow a clinician to selectively test whether or not 55 
a substantially fluid-tight seal has been established between 
the ring 30 and the first surface 8SS of the tissue wall 8SO 
when the ring 30 is moved towards the distal end of the outer 
tube 10 and into engagement with the tissue wall 8SO. For 
example, a clinician may operably engage a fluid source (such 60 
as a saline solution bag) with the seal testing aperture 36 
(which may comprises a luer lock connector or other connec-
tor for operably engaging the fluid source) and introducing a 
fluid via seal testing aperture 36 and observing the interface 
between thering 30 and the first surface 8SS of the tissue wall 65 
8SO to see if any substantial amount of fluid emerges. If no 
fluid is readily visible, a clinician may be reasonably assured 
14 
that the seal formed between the ring 30 and the tissue wall 
8SO is substantially fluid-tight. By assessing the seal formed 
between the ring 30 and the tissue wall 8SO, a clinician may 
determine if it is medically safe to introduce the coring device 
2 via the guide conduit defined in the outer tube 10 (i.e. 
determine if blood loss is likely to occur between the ring 30 
and the first surface8SS ofthetissuewall 8SO when the coring 
device 2 (and the coring cylinder 6S thereof) is advanced 
through the tissue wall 8SO as shown in FIG. SC). 
In some embodiments, the seal testing aperture 36 may also 
serve an alternative function for rotationally securing the ring 
30 relative to and the first surface 8SS of the tissue wall 8SO. 
For example, a clinician may insert a needle and/or other 
elongate spike through the seal testing aperture 36 defined in 
the ring 30 and substantially into the tissue wall 8SO. The 
interaction of the needle and/or spike with the ring 30 (via the 
seal testing aperture 36) and the tissue wall 8SO may thus 
reduce a chance that the ring 30 (and the helical attaching 
device lS extending from the outer tube 10) are rotatable 
relative to the tissue wall 8SO such that the ring 30 and the 
helical attaching device lS may be less prone to "backing out" 
of the tissue wall 8SO once the seal is established between the 
ring 30 and the first surface 8SS of the tissue wall 8SO. 
In some additional embodiments, as shown generally in 
FIG. 7, thering 30 (and/or the sealingmember3S that maybe 
operably engaged therewith) may define a substantially flat 
and/or disc-shaped annular sealing surface that may be con-
figured for establishing a substantially fluid-tight seal 
between the ring 30 and a substantially flat first tissue surface 
8SS about an aperture defined in the tissue wall 8SO. 
Referring to FIG. SC, for example, some embodiments 
may further comprise an inner tube 40 defining a conduit 
aperture extending axially therethrough. The inner tube 40 
may be configured for insertion into the guide aperture 
defined by the outer tube 10. In some embodiments, as shown 
in FIG. 6, the inner tube 40 may be carried by a coring device 
2 that may be advanced through the guide aperture defined by 
the outer tube 10 and configured for substantially simulta-
neously removing a tissue core 8SOa to define an aperture in 
the tissue wall 8SO and operably engaging the inner tube 40 
with the outer tube 10 so as to establish and/or maintain a 
reliable and engageable pathway for fluid communication 
between the first and second surfaces 8SS, 8S3 of the tissue 
wall 8SO. In order to facilitate the secure engagement of the 
outer tube 10 with the inner tube 40, some conduit device 1 
embodiments may comprise a first securing device 13 oper-
ably engaged with a proximal end of the outer tube 10 and a 
complementary second securing device 43 operably engaged 
with a proximal end of the inner tube 40. According to such 
embodiments, as shown generally in FIG. 2, the second secur-
ing device 43 may be configured for selectively operably 
engaging the first securing device 13 so as to operably engage 
the inner tube 40 with the outer tube 10. As shown generally 
in FIG. 6, the second securing device 43 may comprise one or 
more deformable pawls configured for selectively operably 
engaging the first securing device 13 as shown in FIG. 2 
(wherein the first securing device 13 comprises one or more 
ridges disposed on a proximal portion of the outer surface of 
the outer tube 10). 
It is appreciated that the conduit device embodiments 
described herein are only example conduit device configura-
tions and that many other device configurations may be uti-
lized with various system components described. For 
example, a conduit device may not necessarily require an 
attaching device, an inner tube, an outer tube, and/or a coring 
member, as described, but may simply include a tube body 
and an attaching device, or may be delivered utilizing other 
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delivery instruments and/or other techniques. Thus, addi-
tional aspects of the system and device components may be 
utilized with any number of conduit device configurations, as 
generally described below. 
Delivery Techniques 
As shown generally in FIG. 6, some system embodiments 
for installing a conduit device 1 may further comprise a 
coring device 2 configured for advancing through the conduit 
aperture defined by the inner tube 40 and through the tissue 
wall 8SO to define an aperture therein by removing a tissue 10 
core 8SOa (see FIG. SD, for example, showing the coring 
device 2 removing a tissue core 8SOa and collecting the tissue 
core 8SOa in a coring bore defined by a coring cylinder 6S. As 
shown generally in FIGS. SC and 6, the coring device 2 may 
16 
(such as the ventricular apex). It should be understood that 
various embodiments of the present invention may be utilized 
for installing the conduit device 1 for use in medical proce-
dures that may include, but are not limited to: bypass; cardiac 
valve repair or replacement; attachment of a ventricular assist 
device; and combinations of such procedures. As shown in 
FIG. SA, an exemplary process for installing a conduit device 
1 may begin with the implantation of the attaching device lS 
in the tissue wall 8SO. As described herein, the attaching 
device lS may comprise a helical spring and/or coil config-
ured for advancing along a helical path at least partially 
through the tissue wall 8SO such that at least a portion of the 
attaching device 8SO becomes disposed substantially 
between the first surface 8SS and the opposing second surface 
8S3 of the tissue wall 8SO when the outer tube 10 is rotated 
relative to the first surface 8SS of the tissue wall 8SO. In some 
embodiments, the attaching device lS may be sized such that 
the axial length of the attaching device lS does not extend 
substantially distal to the second surface 8S3 of the tissue wall 
be further configured for carrying the inner tube 40 through 15 
the aperture such that the inner tube 40 extends at least par-
tially through the aperture (see FIG. SF, for example) so as to 
establish fluid communication between the first 8SS and sec-
ond 8S3 surfaces of the tissue wall 8SO. In some embodi-
ments, as shown in the cross-sectional side view of FIG. SD, 
the coring device 2 (and/or the coring cylinder 6S thereof) 
defines a coring bore extending axially therethrough config-
ured for receiving the tissue core 8SOa removed by the coring 
cylinder 6S. 
20 8SO. 
As shown in FIGS. SC-SE, the coring device 2 may also 25 
comprise a piercing rod 60 slidably advancable and retract-
able within the coring bore defined by the coring device 2. 
The piercing rod 60 may further comprise a retrieval device 
61 operably engaged with a distal end thereof and configured 
for axially retaining the tissue core 8SOa removed by the 30 
coring cylinder 6S. In various embodiments, the retrieval 
device 61 may include, but is not limited to: a barb; a hook; 
corkscrew; expandable balloon; a self-expanding structure; 
and/ or other device configured for initially piercing the tissue 
wall 8SO so as to be capable of retrieving the tissue core 8SOa 35 
removed by the coring device 2 as described further herein. 
As shown generally in FIG. SC, the piercing rod 60 may be 
configured for advancing so as to pierce the tissue wall 8SO 
prior to removal of the tissue core 8SOa (i.e. prior to the 
advancement of the coring cylinder 6S through the tissue wall 40 
8SO). Furthermore, as shown generally in FIG. SE, the pierc-
ing rod 60 may be further configured for retracting after 
removal of the tissue core 8SOa such that the tissue core 8SOa 
In some embodiments, wherein the attaching device com-
prises a conical and/or "radially-expanding" helix, the attach-
ing device lS may act to compress at least a portion of the 
tissue wall 8SO radially inward and towards an outer surface 
of the innertube 40 so as to establish a substantially fluid-tight 
seal between the outer surface of the inner tube 40 and the 
portion of the tissue wall 8SO that has been urged radially 
inward by the conical and/or radially-expanding helix of the 
attaching device lS. Furthermore, in embodiments wherein 
the attaching device lS comprises a conical and/or "radially-
expanding" helix, the attaching device lS may act to com-
press at least a portion of the tissue wall 8SO radially inward 
such that the portion of the tissue wall 8SO may be more 
readily received by ring 30 (which may comprise a frusto-
conical structure configured for receiving the compressed 
portion of the tissue wall 8SO). As shown in FIG. SB, the 
conduit device 1 installation process may continue with the 
advancement and/or tightening of the ring 30 towards a distal 
end of the outer tube 10. As described herein, some conduit 
device 1 embodiments of the present invention may comprise 
a nut 20 operably engaged about an outer surface of the outer 
tube 10 proximal to the ring 30. In some such embodiments, 
the nut 20 may comprise threading on at least a portion on an 
inside surface thereof, wherein the threading is configured for is retrievable via a proximal end of the coring device 2. In 
some system embodiments for installing a conduit device 1, 
the coring device 2 may further comprise a handle 63 oper-
ably engaged with a proximal end of the coring device 2 
(and/or a proximal end of the coring cylinder 6S). According 
45 cooperating with the threading 11 on at least a portion of the 
outside surface of the outer tube 10. The nut 20 may thus be 
configured to cooperate with the ring 30 to advance the ring 
30 towards the distal end of the outer tube 10, and therefore 
into contact with the first surface 8SS of the tissue wall 8SO. to such embodiments, as shown generally in FIG. 6, the 
handle 63 may define a tissue core chamber 62 in communi- 50 
cation with the coring bore defined by the coring cylinder 6S. 
As shown in FIG. SE, the tissue core chamber 62 may thus be 
configured for receiving the tissue core 8SOa retrieved by 
retraction of the piercing rod 60 (and the retrieval device 61 
operably engaged with a distal end thereof). In order to allow 55 
a clinician to positively identify and/or confirm the removal 
and retraction of the tissue core 8SOa, in some system 
embodiments at least a portion of the handle 6S may be 
provided with a substantially transparent material (such as a 
transparent polycarbonate polymer, for example) such that 60 
the tissue core 8SOa received by the tissue core chamber 62 
may be visible (to a clinician or an endoscopic imaging 
device, for example) from a position substantially outside the 
handle 63. 
As shown generally in FIG. SB, once the nut 20 and ring 30 
are advanced distally (which may be accomplished by hand-
tightening the nut 20), the ring 30 may cooperate with the 
attaching device lS such that at least a portion of the tissue 
wall 8SO is secured between the attaching device lS and the 
ring 30 so as to securely operably engage the outer tube 10 
with the tissue wall 8SO. 
As shown in FIG. SC, once the outer tube 10 is stabilized 
relative to the tissue wall 8SO, a coring device 2 (which, in 
some embodiments, as shown in FIG. 6, may be configured 
for carrying an inner tube 40), may be inserted into the guide 
aperture defined axially within the outer tube 10. As described 
herein with respect to FIG. 6, the coring device 2 may com-
prise a coring cylinder 6S configured for advancing through 
the conduit aperture defined by the inner tube 40 and through 
FIGS. SA-SG illustrate the various steps involved in the 
utilization of one embodiment of the system of the present 
invention for installing a conduit device 1 in a tissue wall 8SO 
65 the tissue wall 8SO to define an aperture therein by removing 
a tissue core 8SOa (see FIG. SD, for example). Referring again 
to FIG. SC, some embodiments may further comprise a pierc-
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ing rod 60 slidably advancable and retractable within the 
coring bore defined by the coring cylinder 6S. The piercing 
rod 60 may comprise, in some embodiments, an elongate 
proximal end that may be manipulated (i.e. extended and/or 
retracted) by a clinician in order to initially pierce the tissue 
wall 8SO and/or retract the tissue core 8SOa removed there-
from (as described further herein). As shown in FI GS. SD and 
SE, the piercing rod 60 may further comprise a retrieval 
device 61 operably engaged with a distal end thereof and 
configured for axially retaining the tissue core 8SOa removed 10 
by the coring cylinder 6S. The piercing rod 60 may be con-
figured for advancing so as to pierce the tissue wall 8SO prior 
to removal of the tissue core 8SOa (i.e. prior to advancement 
of the coring cylinder 6S). Furthermore, as shown in FIG. SE, 
the piercing rod 60 may be further configured for retracting 15 
after removal of the tissue core 8SOa such that the tissue core 
8SOa is retrievable via a proximal end of the coring device 2. 
18 
thereof) is retracted and removed from the inner tube 40, a 
clamp C may be applied to a proximal end of a graft portion 
that may be operably engaged with the inner tube 40 of the 
conduit device 1. In other embodiments, the inner tube 40 
may comprise one or more ridges defined on an outer surface 
of the proximal end thereof that may be configured for receiv-
ing a deformable cap or other cover for temporarily and/or 
semi-permanently closing the aperture defined by the 
installed conduit device 1. As described herein, the conduit 
device 1 may be utilized as a portion of a two-part bypass 
system that may comprise another corresponding conduit 
device 1 installed in a tissue wall 8SO defining a wall of the 
mammalian aorta, for example. The two corresponding con-
duit devices 1 may then be operably engaged with one another 
via a valve device so as to form an apicoaortic connection 
(AAC) in order to bypass, for example, a faulty valve or other 
mechanical defect present in a subject's cardiac anatomy. 
FIGS. 8-11 illustrate various perspective and cross-sec-
tional views of an example conduit delivery instrument, 
20 which includes an inner lumen 80S and an outer lumen 810 
which is adapted to carry the inner lumen 80S therethrough. 
FIG. 8 illustrates a cross-sectional view of an inner lumen 
80S, FIG. 9 illustrates a cross sectional view of an outer lumen 
As shown in FIGS. SD and 6, the coring device 2 may be 
further configured for carrying the inner tube 40 through the 
aperture such that the inner tube 40 extends at least partially 
through the aperture so as to establish fluid communication 
between the first and second surfaces 8SS, 8S3 of the tissue 
wall 8SO (see also, FIG. 3, for example). As described herein, 
with respect to various conduit device 1 embodiments of the 
present invention the outer tube 10 may comprise a first 25 
securing device 13 operably engaged with a proximal end 
thereof and the inner tube 40 (carried, for example, by the 
coring device 2 into position relative to the outer tube 10) may 
comprise a complementary second securing device 43 oper-
ably engaged with a proximal end thereof. As shown gener- 30 
ally in FIG. 3, the second securing device 43 (which may 
comprise a deformable pawl, for example) may be configured 
for selectively operably engaging the first securing device 13 
(which may comprise a complementary at least one ridge 
disposed on an outer surface of the outer tube 10) so as to 35 
positively and securely operably engage the inner tube 40 
with the outer tube 10. 
Referring again to FIG. SE, the coring device 2 may, in 
some embodiments, comprise a handle 63 operably engaged 
with a proximal end of the coring device 2. As described 
herein, the handle 63 may define a tissue core chamber 62 in 
communication with the coring bore defined, for example, by 
the coring cylinder 6S. The tissue core chamber 62 may thus 
be configured for receiving the tissue core 8SOa retrieved by 
retraction of the piercing rod 60 (and the retrieval device 61 
operably engaged with a distal end thereof). In some embodi-
ments, the coring device 2 may also define a fill aperture 
configured for operably engaging a source of saline solution 
or other fluid that may be used to substantially flood the 
coring bore defined by the coring cylinder 6S and the tissue 
core chamber 62 so as to reduce the chance of introducing gas 
bubbles (i.e. air bubbles) into an interior chamber defined by 
the tissue wall 8SO when the coring device 2 is introduced via 
the outer tube 10. 
As described generally herein with regard to the various 
system embodiments of the present invention, the conduit 
device 1 installation process may advantageously allow a 
clinician to visually confirm that the tissue core 8SOa 
removed by the coring cylinder 6S has been completely and 
cleanly removed from the aperture defined in the tissue wall 
8SO. For example, in some embodiments, at least a portion of 
the handle 63 may comprise a transparent material such that 
the tissue core 8SOa received within the tissue core chamber 
810, while FIGS. 10 and 11 illustrate cross-sectional and 
perspective views of the inner lumen 80S inserted into the 
outer lumen 810, according to one embodiment. 
With reference to FIG. 8, the inner lumen 80S may gener-
ally be an elongated tube member having a passage defined 
therethrough that allows instruments or other therapy to be 
delivered through the inner lumen 80S and into the cavity or 
other side of a tissue wall. The inner lumen 80S may serve to 
provide access at least partially through a tissue wall, such as 
may be achieved by the inner tube 40 of the conduit device 
described with reference to FI GS. 1-SG. At or near the proxi-
mal end of the inner lumen 80S, at least one flow control 
mechanism 807 may be provided to limit fluid flow when the 
inner lumen 80S is inserted into the outer lumen 810 and in 
fluid contact with bodily fluid during use. As shown in FIG. 8, 
one embodiment of a flow control mechanism 807 may be a 
40 clamp valve having a pliable material forming at least a por-
tion of the conduit and adaptable to receive a clamping instru-
ment (e.g., surgical clamp, hemostat, etc.), such as is shown 
with reference to FIG. SF. In another embodiment, the clamp 
valve of the flow control mechanism 807 may be in operable 
45 communication with an integrated clamp that can be selec-
tively actuated by an operator, and which does not require the 
use of an additional instrument to close the clamp valve. 
Other flow control mechanisms may be utilized, such as, 
but not limited to, duck bill valves, globe valves, single or 
50 multiple leaflet valves, breast pump valves, diaphragm 
valves, and the like. For example, the delivery system with an 
inner lumen 100 is shown in FIG. 13 as including a one-way 
valve 130, such as a duck-bill valve, positioned intermedi-
ately along the length of the delivery system 100. This one-
55 way valve 130 may allow passage of a lumen and/or instru-
ment through the valve 130, but prevent fluid from flowing 
proximally from the valve 130. It is appreciated that one or 
more other valve mechanisms can be included, such as, but 
not limited to, globe valves, single or multiple leaflet valves, 
60 breast pump valves, diaphragm valves, and the like. These 
valves may be used by themselves or in combination. It is 
further appreciated that the placement of the one-way valve 
130, or other valves included, may be at one or more different 
62 may be directly visible by a clinician and/or an endoscopic 
imaging device from a position substantially outside the 65 
handle 63. As shown in FIGS. SF and SG, after the coring 
device 2 (and the tissue core 8SOa retained in the handle 63 
locations along the length of the delivery system 100. 
According to one embodiment, an additional diaphragm 
valve may be included at or near the proximal end of the 
delivery system 100. FIGS. 14A-14C illustrate an example 
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diaphragm valve 135, according to one embodiment. A dia-
phragm valve 135 may, alone or in combination with other 
valves, improve blood loss control and provide easy access 
with a lumen and/or instrument (or any other device) through 
the delivery system. An example diaphragm valve 135 may be 
20 
This dual action system may be conformed from one or mul-
tiple of the means described above or one or multiple of this 
means and using an actuator such as a button, lever or lock. 
Therefore, initial action on the actuator will then allow for 
secondary action which will release the attaching device from 
the delivery system. Such a dual action system will increase 
the security when using the device in medical procedures. 
a rotation collapsible diaphragm valve, diagrammatically 
represented in FIGS. 14A-14B, which consists of at least two 
aligned conduits 205, 210 connected by a flexible conduit 
215. According to one embodiment, the two aligned conduits 
205, 210 may further include alignment arms or collars 220 to 
maintain alignment and relative position and distance of the 
conduits 205, 210 with respect to each other. A flexible con-
duit 215 may be formed from any suitable pliable material 
having elastic or viscoelastic properties and allowing defor-
mation thereof. 
As shown in FIG. 9, the outer lumen 810 also may option-
ally include at least one flow control mechanism 816. Accord-
lO ing to the embodiment, the flow control mechanism 816 is 
provided at or near the proximal end of the outer lumen 810 
for controlling fluid flow therethrough, such as prior to inser-
tion of the inner lumen 805 and/or after removal of the inner 
In use, rotation of a first conduit 205 with respect the 
second conduit 210 causes the flexible conduit 215 to twist 
and collapse within itself, therefore reducing inner diameter 
of the passage therethrough. In one embodiment, complete 
closure of the passage may be achieved by increased turning 
of the conduits 205, 210 relative to each other. In another 
embodiment, if an instrument, lumen, or other medical instru-
ment is inserted through the conduit, then the flexible conduit 
215 may close onto the instrument, lumen, or other device and 
create a fluid seal therearound. 
15 lumen 805. According to the embodiment shown, the flow 
control mechanism 816 is a clamp valve, such as described 
with reference to the inner lumen 805. However, it is appre-
ciated that, according to other embodiments, other flow con-
trol mechanisms may be utilized, such as, but not limited to, 
20 duck bill valves, globe valves, single or multiple leaflet 
valves, breast pump valves, diaphragm valves, and the like. 
Moreover, in some embodiments, the outer lumen 810 may be 
referred to as a multi-valved port, indicating that an outer 
lumen 810 may have multiple valves for controlling fluid flow 
With reference to FIG. 15 and FIG. 16, an embodiment 
with an inner tube represented by a medical sheath 3100, 
which may be flexible, semi-flexible or rigid may be used to 
establish fluid communication between the tissue walls. The 
proximal end of the sheath may have one or multiple valves 
including but not limited to a duckbilled valve 3400 and/or a 
collapsible diaphragm valve 3500 of FIG. 15. In order to 
facilitate the insertion of a medical sheath 3200, it may be 
delivered mounted on a dilator 3210 with an axial orifice for 
25 therethrough, which may be the same or different types of 
valves. 
FIGS. 10-11 show the inner lumen 805 inserted within the 
outer lumen 810, and an attaching device 820. It is appreci-
ated, however, that according to other embodiments the outer 
30 lumen 810 can be utilized with a different attaching device, 
such as one including hooks, barbs, wires, pins, arms, sutures, 
suction forces, a flange, any combination thereof, and the like. 
Multiple of these attaching devices may be used in conjunc-
tions in the system in order to improve anchoring to the tissue. 
a guidewire 3200 as shown in FIG. 16. 
With reference to FIG. 9, an outer lumen 810 is also shown 
as a generally elongated tube member having a passage 812 
defined therethrough. The passage 812 is shaped and sized 
having an inner radius large enough to accept at least a portion 
35 In some preferred embodiments multiple coils may be used in 
conjunction, these coils may be or may not be centered on the 
same rotational axis. In other embodiments both suction and 
a coil may be used to attach the system to the tissue surface. 
of the outer lumen 810. According to one embodiment, the 40 
distal end of the outer lumen 810 can be adapted to receive an 
attaching device 820, such as a coiled attaching device 15 
having an outer flange 30, as shown in FIG. 12 and described 
above with reference to FIGS. l-5G, or any other attaching 
means. In the embodiment shown by FIG. 9, the distal end of 45 
the outer lumen 810 includes threads 814 to threadably 
receive an attaching device 820. The threads 814 are shown 
here formed in an inner surface; though they may be formed 
on another portion of the lumen 810, as desired and depend-
ing upon the design and configuration of the attaching device 50 
820. According to other embodiments, instead of threads, the 
distal end may include other attachment means for securing 
an attaching device 820 to the outer lumen 810, such as, but 
not limited to, mechanical means, such as tabs, pins, screws, 
clamps, threads, hooks, interference fit, friction fit, etc., mag- 55 
netic means, chemically bonded, and the like. According to 
various embodiments, the attaching device 820 may be 
releasably or permanently secured. At the proximate end of 
the multi-valve port threads 815 or other releasable locking 
mechanism may be used to attach a cap or a multiple access 60 
port device to the outer lumen 81 
According to one embodiment shown in FIG. 13A, a dual 
action mechanism 125 may be provided at or near the distal 
end of the conduit delivery system 100 to release the attaching 
device after the procedure is completed. In this embodiment, 65 
two simple but distinct motions allow releasing the delivery 
system 100 from the attaching device 120 after being capped. 
As shown by FIG. 10, when the inner lumen 805 is inserted 
through the outer lumen 810, at least a portion of the distal end 
of the inner lumen 805 may extend distally from the outer 
lumen 810, providing access at least partially through a tissue 
wall to which the attaching device will be secured. The inter-
action between the different components of the system, such 
as the fit of the inner lumen 805 within the outer lumen 810 
and the various flow control mechanisms 807, 816, provide 
beneficial sealing of the system to prevent blood or other fluid 
loss during use. Although not shown, one or more de-airing 
orifices, as are known, may be included with the inner lumen 
805 and/or the outer lumen 810 to prevent introducing air into 
the patient's vasculature during use. 
According to one embodiment shown in FIG. 13A, a 
motion absorption element 115 may be utilized to allow for 
movement of the distal end (e.g., the attaching device 120) of 
the delivery system 100 in all directions, or universally, such 
as radially and laterally. Thus, the motion absorption element 
115 compensates for the movement of the tissue, such as a 
beating heart or other organ, while holding the outer lumen 
statically in place, reducing the risk of tearing the tissue. 
According to one embodiment, as shown in FIG. 13A, the 
motion absorption element 115 may be configured as an 
expandable tube, such as tube having an accordion-type 
shape, allowing for movement at the motion absorption ele-
ment 115. In other embodiments, the motion absorption ele-
ment 115 may be constructed from a pliable material having 
elastic or viscoelastic properties that compensate for the 
motion of the tissue. 
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In yet another embodiment, such as shown in FIG. 13C, a 
jointed element, such as a universal-type joint or a socket-
type joint 116, can be utilized to be a motion absorption 
element to compensate for motion or rotation of the distal end 
of the delivery system 100 when anchored onto the tissue. The 
universal joint 116 may also be accompanied but a flexible 
section 117 is some cases where the joint is considered to be 
rigid axially. The motion absorption element, however, 
should allow for the transfer of torque and/or other rotational 
or translational force applied to the proximal end of the deliv- 1 o 
ery system 100, such as when inserting an attaching device 
120 through the tissue, or removing an attaching device 120. 
According to the embodiment such as shown in FIGS. 13A 
and 13B, the delivery system may include an outer lumen 
with an extendable body section that allows for increasing or 15 
decreasing the overall length of the outer lumen. An extend-
able body section 110 thus allows adjusting the overall length 
of the delivery system 100 and controlling the distance from 
the tissue surface to the proximal end of the delivery system 
100. Adjusting the length advantageously allows treating 20 
patients having different weights, body sizes, and anatomies. 
According to various embodiments, the extendable body sec-
tion 110 may be, but is not limited to, an extendible tube 112 
as showninFIG.13B, a series of telescopic conduits as shown 
in FIG. 13A, threaded conduits, and the like. For example, 25 
according to one embodiment, the extendable body section 
110 may include multiple telescoping tubular members in 
cooperative communication and adapted for selective exten-
sion and retraction. The telescoping tubular members may be 
in sliding communication, wherein a translational force 30 
applied to at least one of the tubular members cause extension 
or retraction of the extendable body section 110. 
According to another embodiment, the extendable body 
section may include multiple tubular members in threaded 
communication. For example, an outer tubular member may 35 
have threads formed on an inner surface and an inner tubular 
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embodiment this flange may have internal fluid communica-
tions or channels which could allow for suction therethrough 
and aid in the attachment of the device to the tissue surface. 
At FIG. 17B, a piercing or cutting instrument 825 can 
optionally be utilized to perforate the tissue wall through the 
approximate center of the attaching device 820, in a manner 
similar to that described with reference to FIG. SC.According 
to one embodiment, the piercing element 825 is attached to 
the distal end of the inner lumen 805 (e.g., releasably 
attached) and thus can be delivered through the passage of the 
outer lumen 810. According to one embodiment, the piercing 
element 825 may have a sharp tine or other member utilized 
to perforate the tissue. The piercing element 825 may option-
ally include an inner passage or bore to allow passing the 
piercing element 825 over a guide wire. In one embodiment, 
a sharpened boring element can be used to perforate the tissue 
wall and create a tissue plug, which defines the approximate 
size of the puncture or access site through the tissue wall. 
Additionally, to retrain any loose tissue, an attaching element 
can be utilized to grasp the tissue which is being cut and/or 
released by the cutting tool. This attaching element may be a 
coil, a clamp, jaws, a series ofhooks, barbs, pins, expanding/ 
collapsing surfaces, and the like. 
At FIG. 17C, after the piercing element 825 is removed 
from the proximal end of the outer lumen 810 and detached 
from the distal end of the inner lumen 805, the inner lumen 
805 is re-inserted through the passage of the outer lumen 810, 
to provide communication through the tissue wall. While 
maintaining control of blood flow, such as by utilizing the 
flow control mechanisms described above, different medical 
instruments or devices may be used through the inner lumen 
805 to treat, provide therapy, and/or diagnose conditions 
within the anatomical structure, as shown in FIG. 17D. After 
providing the desired procedure, therapy or diagnosis, the 
inner lumen 805 may be retrieved and a plug or other closure 
means is provided to the attaching device 820, as shown in 
FIG. 17E. At FIG. 17F, after having closed the attaching 
device 820 (or otherwise sealed the tissue), the outer lumen is 
removed from the attaching device 820 and the patient, leav-
member may have complementary threads formed on an 
outer surface. Turning one of the outer or inner tubular mem-
ber in a first direction with respect to the other tubular mem-
ber will thus cause the extendable body section to expand in 
length and turning one of the outer or inner tubular member in 
40 ing the attaching device 820 secured to the tissue wall. It is 
appreciated that, according to various embodiments, the 
attaching device 820 may be left implanted for a period of 
time or may be removed upon permanently sealing the tissue 
wall. 
a second direction opposite the first direction with respect to 
the other tubular member will thus cause the extendable body 
section to retract in length. In a further example, the extend-
able body can be constructed from an accordian-like corru- 45 
gated or extendible tube that may change its axial length by 
changing the angular relations between the different seg-
ments of the tube. 
FIGS. 18A-18B illustrate schematic and cross-sectional 
views of a delivery system 100 that may be utilized with a 
guide wire, in accordance with one embodiment of the inven-
tion. Therefore, according to this embodiment, the delivery 
system 100 may be utilized as an over-the-wire system, which It is appreciated that, according to various embodiments, 
the extendable body section 110 may only comprise a portion 50 includes a guide wire (not shown), adilator510, in addition to 
the other delivery system 100 components, such as are 
described below. 
of the outer lumen 105, whereas another portion of the outer 
lumen 105 may have a fixed length or is not otherwise adjust-
able. Moreover, it is appreciated that other aspects of the 
delivery system 100 may likewise include adjustable mem-
bers to adjust relative lengths, such as an inner lumen, con- 55 
duit, or instrument insertable through the outer lumen 105. 
FIGS.17 A-17F show various detailed views of an example 
use providing access through a tissue wall, according to one 
embodiment. At FIG. 17 A, an attaching device 820 secured to 
an outer lumen 810 is delivered to the surface of the tissue 60 
wall (not shown) through a small incision. The attaching 
device 820 can use an anchoring mechanism, such as, but not 
limited to, a coil to releasably attach to the tissue wall Accord-
ing to one embodiment, a flange of the attaching device 820 
may also facilitate urging tissue radially inwards to improve 65 
attachment of the attaching device 820 and sealing of the 
tissue around the inner lumen 805 to be delivered. In some 
In use, a guide wire is initially inserted into the ventricle, 
followed by a dilator 510 that carries the inner lumen 515. 
Thus, the dilator 510 includes an inner passage 505 that is 
adapted to pass over the guide wire. According to this 
embodiment, which may differ from various other embodi-
ments, the inner lumen 515 can be delivered over the dilator 
510 and inserted into the tissue wall prior to securing the 
attaching device 120 thereto. Upon positioning the inner 
lumen 515 through the tissue wall as desired, the outer lumen 
520 carrying the attaching device 120 is advanced over the 
inner lumen 515 and secured to the tissue wall via the attach-
ing device 120 (such as according to any means described 
herein or in the referenced patents or applications). According 
to one embodiment, a flow control mechanism, such as a 
collapsible diaphragm 135, as described with reference to 
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FIGS. 14A-14C, may be actuated to seal the inner lumen 515 
within the outer lumen 520. After positioning the outer lumen 
520, the dilator 510 is retrieved allowing fluid communication 
through the tissue wall (e.g., into a ventricle, etc.). The guide 
wire may be retrieved at this stage, or at a previous stage such 5 
as after positioning the dilator 510. 
Blood or other fluid flow through the inner lumen 515 may 
be controlled by a flow control mechanism, such as a duck bill 
valve 525 (or other valve mechanism, as described herein) at 
or near the proximal end of the inner lumen 515. The duck bill 1 o 
valve 525, or other valve mechanism, may therefore allow 
selective delivery of instruments or other therapeutic means 
through the inner lumen 515, while still limiting fluid loss 
through the proximal end of the inner lumen 515. Upon 
completion of the procedure, the inner lumen 515 may be 15 
retrieved and either the attaching device 120 or the tissue wall 
may be closed. For example, a small coil or other device for 
urging the tissue in an inward radial direction may be utilized 
to seal the tissue wall or a plug, cap, or other closure device 
may be secured to the attaching device 120 if the attaching 20 
device is left implanted. After removal of the inner lumen 515, 
the collapsible diaphragm 135 (or other flow control mecha-
nism) may be utilized to limit or prevent fluid flow proximally 
through the outer lumen 510. Thus, a coil or other closure 
device delivery instrument may be inserted through the outer 25 
lumen 510 while the collapsible diaphragm 135 still serves to 
limit blood or other fluid flow through the outer lumen 510 
while sealing the tissue wall or cap. It is appreciated that the 
delivery system 100 illustrated and described with reference 
to FIGS. 18A-18B may also include any other features, such 30 
as additional flow control mechanisms (e.g., globe valves, 
single or multiple leaflet valves, breast pump valves, dia-
phragm valves, rubber membranes, etc.), a steerable lumen 
tip, an extendable body section, a motion absorption element, 
a de-airing orifice, different attaching device configurations, 35 
or other features described herein or in the referenced patents 
and applications. 
FIGS. 19A-19L show the main steps of a preferred "over 
the wire" procedure using the different components of the 
system described above. FIG. 19A illustrates a guide wire 40 
1200 inserted in the access site of the tissue wall 850. FIG. 
19B illustrates using the guide wire 1200 where the sheath 
1215 is inserted riding on a dialator 1210. FIG. 19C illustrates 
a port 1220 anchored onto the ventricle by rotationally insert-
ing the primary/anchoring coil 1212. FIG. 19D illustrates 45 
closure of the iris diaphragm valve 1225 stabilizing the sheath 
1215 with respect to the conduit. FIG. 19E illustrates a dilator 
and guide wire removed. FIG. 19F illustrates the clinical 
procedure (introduction of an angioplasty balloon) performed 
through the port system. FIG. 19G illustrates the retraction of 50 
the sheath 1215 and closing of the iris diaphragm valve 1225 
to prevent blood loss. FIG. 19H introduces the plug delivery 
tool 1230 into the system through sealing diaphragm before 
opening the iris diaphragm valve 1225. FIGS. 19I-19J illus-
trate the sealing of the orifice using the plug 1235. FIG. 19K 55 
illustrates detaching the plug delivery device 1230 from the 
plug 1235 and retracting. Closing the iris diaphragm is 
optional. FIG. 19L illustrates that the large coil 1212 is left in 
place after the plug 1235 is delivered. Many modifications to 
the steps of the procedure are possible as enabled by the 60 
various additional features described herein and depend on 
the specific clinical treatment desired. 
FIG. 20 illustrates an example multiple access port device 
1400 adapted for securing to the proximal end of an outer 
lumen. The multiple access port device 1400 may include 65 
multiple individual ports 1405a-1405n which are each in 
fluid communication with an attachment end 1410, and which 
24 
allow using multiple different instruments to enter in com-
munication with the outer lumen. All or a portion of the 
multiple access port device 1400 may be configured from a 
biocompatible pliable material, such as from a natural or 
synthetic rubber, or other polymer material, allowing flexible 
use of the individual ports 1405a-1405n. The attachment end 
1410 can releasably (or permanently) secure to the proximal 
end of the outer lumen, providing fluid communication from 
each of the individual ports 1405a-1405n to the inner passage 
of the outer lumen. 
The multiple access port device 1400 may further include 
one or more flow control mechanisms, which may be in 
operable communication with one or more of the individual 
ports 1405a-1405n and/or with the converging portion of the 
device 1400. The flow control mechanisms may be any 
mechanism allowing selective flow through the respective 
passage, such as, but not limited to, clamp valves, duck bill 
valves, globe valves, single or multiple leaflet valves, breast 
pump valves, diaphragm valves, and the like. In addition, one 
or more de-airing orifices 1415, as are known, may be 
included with the multiple access port device 1400 to prevent 
introducing air into the patient's vasculature during use. In 
other embodiments, however, the de-airing orifice may be 
associated with the outer lumen 810 or another portion of the 
system. Although the multiple access port device 1400 is 
shown and described as being attached to the outer lumen, in 
other embodiments, a multiple access port device 1400 may 
be attached directly to the attaching device or attached to the 
inner lumen. 
FIGS. 21A-21B illustrate various embodiments of a deliv-
ery system having an inner lumen with a steerable tip. For 
example, as shown in FIG. 21A, the inner lumen 300 may be 
directed in two or three dimensions in order to direct the 
therapeutic devices passing through the lumen 300 in the 
desired direction. According to the embodiment, as shown in 
FIG. 21A, the steerable tip 305 may be guided utilizing a 
distal section that is flexible and a system of wires, rods, or 
other members extending proximally for use by the operator 
to exert forces at different sections of the steerable tip 305, 
deforming the lumen 300 in a controlled direction. The steer-
able tip 305 may be achieved according to techniques similar 
to those utilized for steerable catheters, as are known. 
FIG. 21B illustrates another embodiment of a steerable 
inner lumen 400. According to this embodiment, a guide wire 
405 is provided over which the inner lumen 400 is passed and 
a guiding tip 410 is provided, extending from the distal end of 
the inner lumen 400. The guiding tip 410 may have a curved 
shape (or other preformed shape) such that the guiding tip 410 
causes the guide wire 405 to approximately follow the curve 
of the guiding tip 410. As the guide wire curves, so will the 
inner lumen 400. To provide additional degrees of freedom or 
movement, the inner lumen 400 may be rotated about its 
longitudinal axis to achieve improved steering of the distal 
end of the inner lumen. According to one embodiment, the 
guiding tip 410 includes a guide 415, such as a ring, an eye, a 
channel, etc., which maintains the relationship of the guide 
wire 405 and the guiding tip 410. Furthermore, a control 
mechanism 420, such as a handle, a trigger, or other suitable 
means, may be in operable control with the guiding tip 410 to 
allow extending or retracting the guiding tip 410 and/or to 
rotate the guiding tip 410 and/or the inner lumen 400. In 
further embodiments the inner tube with steerable tip, may be 
a medical catheter or sheath with an steerable distal end. This 
sheath or catheter may be steered by tension on a single or 
multiple wires which run axially within the wall of the device. 
FIGS. 22-23C illustrate perspective views of yet additional 
embodiments of an inner lumen, in which the inner lumen is 
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configured as a collapsible inner lumen. Accordingly, a col-
lapsible inner lumen may be expandable and/or collapsible in 
order to allow delivery of the lumen endovascularly or trans-
cutaneously, such as within a catheter or insertion sleeve. 
Therefore, a collapsible inner lumen can collapse to a com-
pressed state, having a smaller diameter, allowing inserting 
through a smaller orifice, such as may be utilized during 
endovascular or trans-cutaneous procedures. After insertion 
and placement, the collapsible inner lumen can be expanded 
to provide a passage having an increased diameter to allow 10 
inserting instruments and/or administering therapy there-
through. 
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forces separable portions of the tip 1705 apart into an open 
state. A flexible tip 1705 may thus be utilized to control access 
through the inner lumen 1500 and/or to control fluid flow 
through the inner lumen 1500. Moreover, in some embodi-
ments, the ability to selectively control fluid allows for leav-
ing the inner lumen 1500 implanted within a tissue wall to 
enable multiple subsequent accesses therethrough. In some 
embodiments the distal tip of the closure plug may be flexible 
and serve as a valve or port as described below. This expand-
able and/or flexible tip of the closure plug may therefore 
allow for re-access after closure. 
According to various embodiments, an attaching device 
may be closed and/or the tissue wall puncture may be sub-
stantially sealed to close the puncture, to prevent fluid flow 
therethrough, and/or to allow multiple subsequent accesses. 
FIGS. 25A-25B illustrate various example embodiments of 
an attaching device 820 which is adapted to receive a plug 
1800 to substantially seal the attaching device 820. As shown 
in FIG. 25A, a plug 1800 may include a plug end 1805 and an 
opposite threaded end 1810. The plug 1800 is sized and 
shaped to releasably fit within the attaching device 820, being 
inserted from the proximal direction. According to this 
embodiment, the attaching device 820 has inner threads 1815 
Moreover, a collapsible lumen may further facilitate seal-
ing a tissue puncture when inserted therethrough and 
expanded to its expanding state by creating an outward radial 15 
force against the tissue walls. It is thus possible that, in 
embodiments using a collapsible/expandable inner lumen, an 
attaching device need not be a radially expanding coiled 
device or other device that urges tissue in an inward radial 
direction because the collapsible/expandable inner lumen 20 
creates the pressure by urging itself in an outward radial 
direction when in an expanded state. It is appreciated that, in 
some embodiments, an attaching device, an outer lumen, 
and/or any other aspects of the system may likewise be col-
lapsible to allow delivery by trans-cutaneous access. 25 that are complementary to the threads 1810 of the plug 1800, 
as shown in FIG. 25B. It is appreciated, however, that any 
number of releasably attaching techniques can be utilized to 
secure the plug 1800 to the attaching device 820. Upon inser-
FIGS. 22A-D, thus, show a collapsible inner lumen 1500 in 
a collapsed (FIGS. 22A and 22D) and expanded (FIGS. 22B 
and 22D) state. A collapsible inner lumen 1500 may generally 
include an expanding member 1505 and an expandable mem-
brane 1510 provided over the expanding member 1505. Also 30 
as shown in FIG. 22A, in one embodiment, a collapsed inner 
lumen 1500 may serve as a piercing device by forming a 
substantially sharpened tip when the expanding member 
1505 is in a collapsed state. The piercing device may be 
utilized to puncture or otherwise open the tissue through 35 
which the lumen 1500 is to be inserted. The expanding mem-
ber 1505 of FIGS. 22B and 22C is shown as a series of 
elongated members (e.g., expandable barbs, etc.) that may be 
mechanically operated to expand and/or collapse. 
FIGS. 23A-23C illustrate other embodiments of a collaps-
ible inner lumen. With reference to FIG. 23A, an expanding 
member 1520 may be configured as an expanding coil wire or 
helical ribbon selectively expandable within a tube-shaped 
membrane 1510. FIG. 23B illustrates a different expandable 
member 1525 configured in an expanding mesh configura-
tion, such as is utilized for an expanding mesh stent. In one 
embodiment, a membrane 1510 is also provided for use with 
the expanding mesh member 1525. Though, in other embodi-
ments, the expanding mesh member 1525 may be configured 
for use without a separate membrane, whereby the mesh 
arrangement provides a substantially closed surface in an 
expanded or collapsed state. FIG. 23C shows yet another 
embodiment of an expanding member 1530 configured as an 
expanding helix, which expands radially when removed from 
the membrane 1510 to unwind, in a manner similar to an 
unwinding ribbon. Any of the various expanding members 
1505, 1520, 1525, 1530 described herein may be configured 
to expand and/or collapse using one or more of: mechanical 
actuation, inflation, material properties, structural properties, 
electrical excitation, thermal excitation, and/or any combina-
tion thereof. 
FIGS. 24A-23B illustrate an example embodiment in 
which the distal end or tip 1705 of a collapsible inner lumen 
1500 is flexible, allowing it to serve as a valve or port. For 
example, as shown in FIGS. 24A-24B, according to one 
embodiment, the flexible tip 1705 may generally be in a 
closed state until an instrument 1710 (or any other member) 
tion, the distal plug end 1805 fits within a cavity 1820 of the 
attaching device 820, which would otherwise provide fluid 
access therethrough. 
FIGS. 26A-26B illustrate a variation of a plug 1800, which 
includes an extended surface 1905 extending from the plug 
end 1805. The extended surface 1905 is intended to fit within 
the puncture or perforation of the tissue wall so as to further 
improve the sealing abilities of the plug 1800 and the attach-
ing device 820 generally by deforming the tissue and creating 
a seal between the plug end 1805 and the tissue and/or 
between the tissue and the attaching device 820 (e.g., a flange, 
40 ring, etc.). According to one example embodiment, the 
extended surface 1905 may have a smaller diameter than the 
plug end 1805. In one embodiment, as shown in FIG. 26B, a 
conical flange and/or conical coil of the attaching device 820 
may further improve sealing by creating an inward radial 
45 force and urging the tissue against the extended surface 1905. 
As described above, the distal tip of the closure plug may have 
a flexible valve or port, or self sealing membrane, to provide 
re-access to the tissue after closure. 
FIGS. 27 A-27B illustrate perspective views of alternative 
50 embodiments of plug and coil closure systems provided by 
the invention. FIG. 27A shows a plug 1800 (or cap) for 
occluding the attaching device orifice, similar to the plug of 
FIGS. 19J and 26A, having a threaded exterior surface for 
engaging corresponding threads on the interior orifice of the 
55 attaching device 820. The plug configuration permits closure 
of the conduit with a minimal protruding profile. The plug 
1800 can be constructed of any suitable materials, including 
biocompatible rigid polymers or metal alloys, and biodegrad-
able materials. In certain embodiments, the surfaces of the 
60 plug and/or orifice of the attachment device can be coated 
with a biocompatible swellable composition, such as a col-
lagen gel, to facilitate sealing between the plug and the attach-
ment device. The plug can also be coated or impregnated with 
bioactive agents, such as but not limited to thrombolytics, 
65 growth factors, angiogenic agents, and antibiotics. The sur-
faces of the plug and attaching device embodiments can also 
be made textured or porous, such as through casting and laser 
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etching techniques, in order to facilitate tissue ingrowth for 
improved immunological acceptance of the implantation. 
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FIGS. 29A-29B show yet another embodiment for achiev-
ing closure of the tissue wall. According to this embodiment, 
an attaching device 820 may include one or more pledgets 
2205 associated therewith and one or more sutures 2210 to be 
releasably inserted through the pledgets 2205 and a portion of 
the attaching device 820. Thus, the sutures 2210 and/or 
pledgets 2205 may be used to initially close the tissue wall 
after removal of the inner tube but before removing the attach-
ing device 820. According to one embodiment, the pledgets 
FIGS. 27A-27B also illustrate a delivery instrument 2005 
configured for delivering a plug 1800 through an extended 
lumen and for insertion into an attaching device 820. The 
delivery instrument 2005 may be configured with an engage-
ment element 2010 adapted to releasably attach to a plug 1800 
and to allow rotating the plug 1800 during insertion into and 
removal from an attaching device 820. In one embodiment, 
the engagement element 2010 can be a substantially solid end 
piece that includes a receiving feature (e.g., the female or 
male element of a corresponding male/female element on the 
plug 1800), such as, but not limited to, a straight slot, cross-
shaped slot (e.g., for use with a phillips head), a hexagonal 
shape (e.g., for use with an alien head), or any other geometry 
or assembly that allows secure selective insertion of the head 
10 2205 may be pre-mounted onto an inner surface of the attach-
ing device 820 (or flange), such that they can be left behind on 
the surface of the tissue when the attaching device 820 is 
removed. In a further embodiment of the device the inner 
lumen or conduit may be withdrawn from the tissue by adjust-
15 ing a multiple position lock before tightening the suture, so 
that the inner lumen does not interfere with the closure of the 
of a delivery instrument 2005 into a complementary feature 
on the plug 1800. According to other embodiments, any other 
mechanical forces, suction forces, or magnetic forces, or any 20 
combination thereof, may be utilized as part of the engage-
ment element 2010 to provide releasable engagement of the 
delivery instrument 2005 with the plug 1800. 
FIGS. 28A-28B illustrate yet additional closure or sealing 
devices, which operate by compressing or collapsing the tis- 25 
sue at the puncture site in the tissue wall. According to this 
embodiment, the attaching device 820 includes a variable 
radius coiled member 2105 for inserting into the tissue wall 
and securing the attaching device 820 to the tissue wall. The 
variable radius coiled member 2105 may have a relaxed state 30 
2105a, as shown in FIG. 28B and an expanded state 2105b, as 
shown in FIG. 28A. In its relaxed state 2105a, the coiled 
member 2105 includes a narrow section 2110 having a 
decreases radius relative to other portions of the coiled mem-
ber 2105. In its expanded state 2015b, the narrow section 35 
2110 is expanded such that the radius is greater than in its 
relaxed state. Thus, when the coiled member 2105 changes 
from its expanded state to its relaxed state, the tissue is com-
pressed in an inward radial direction at or near the narrow 
section 2110, which in tum facilitates sealing the tissue punc- 40 
ture. This type of coil by itself or with other elements may 
serve to close a puncture or bore in tissue. An hour glass 
shaped coil may also have the closure effects described 
above. 
In the embodiment shown by FIG. 28A-28B, the variable 45 
radius coiled member 2105 may be forced into an expanded 
state 2105b when a plug 1800 (or a lumen or other member) 
is inserted through the approximate center of the coiled mem-
ber 2105 and expanding the narrow section 2110, as shown in 
FIG. 28A. Thus, when the plug 1800 (or a lumen or other 50 
member) is removed, the coiled member 2105 reverts to its 
relaxed state 2105a, allowing the narrow section 2110 to 
compress the tissue inward and seal the tissue wall. 
It is appreciated that, in other embodiments similar to that 
shown in FIGS. 28A-28B, instead of (or in addition to) a 55 
coiled member, one or more barbs, wires, or pins may be 
configured to generally extend from the attaching device 
inward, but allow expansion or displacement by a plug or 
other member. Thus, similar to that shown in FI GS. 28A-28B, 
removal of the plug or other member would cause the barbs, 60 
wires, or pins to compress inward and achieve tissue sealing 
in much the same manner. It is further appreciated that, in 
these and/or other embodiments, any of the members may be 
constructed from shape memory materials (e.g., a shape 
memory alloy, such as Nitinol, etc.) that may be acted on to 65 
induce reverting to its relaxed state, as known, and cause 
inward compression of the tissue wall. 
tissue. During a procedure, the U-sutures or mattress sutures 
2210 may be passed through the pledgets 2205 to close the 
tissue wall. In other embodiments, the sutures 2210 may be 
pre-mounted onto the attaching device 820 and through the 
pledgets 2205. Tightening the sutures 2210 will cause them to 
pass through and separate from the attaching device 820 and 
close the tissue wall, as is known. It is appreciated that the 
sutures 2210 and/orpledgets 2205 may be utilized with any of 
the attaching device and/or conduit embodiments described 
herein. 
Many modifications and other embodiments of the inven-
tions set forth herein will come to mind to one skilled in the art 
to which these inventions pertain having the benefit of the 
teachings presented in the foregoing descriptions and the 
associated drawings. Therefore, it is to be understood that the 
inventions are not to be limited to the specific embodiments 
disclosed and that modifications and other embodiments are 
intended to be included within the scope of the appended 
claims.Although specific terms are employed herein, they are 
used in a generic and descriptive sense only and not for 
purposes of limitation. 
What is claimed is: 
1. A system for use through a tissue wall having a first 
surface and a second surface, the system comprising: 
an attaching device comprising a port defining an opening 
extending along a longitudinal axis of the attaching 
device, and a coil fixedly attached to the port and con-
figured for advancing at least partially through the tissue 
wall such that at least a portion of the coil becomes 
disposed between the first surface and the second sur-
face of the tissue wall; 
an outer tube defining an outer lumen extending along a 
longitudinal axis of the outer tube, the outer tube com-
prising one or more tabs disposed at a distal end of the 
outer tube and configured for releasably attaching to the 
port; 
an inner tube defining an inner lumen extending along a 
longitudinal axis of the inner tube, the inner tube con-
figured for inserting through the outer lumen of the outer 
tube and the opening of the port and at least partially 
through the tissue wall to establish fluid communication 
between the first surface and the second surface of the 
tissue wall; and 
a valve attached to the inner tube, the valve configured for 
controlling fluid flow through the inner lumen and for 
permitting passage of instruments therethrough. 
2. The system of claim 1, wherein the valve comprises a 
multiple leaflet valve. 
3. The system of claim 1, wherein the valve comprises a 
clamp valve, a duck-bill valve, a globe valve, a breast pump 
valve, or a diaphragm valve. 
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4. The system of claim 1, wherein the valve comprises a 
one-way valve. 
5. The system of claim 1, wherein the valve is positioned at 
or near a proximal end of the inner tube. 
6. The system of claim 1, wherein the coil has a radially 5 
expanding helical shape. 
7. The system of claim 6, wherein a radius of the coil 
increases along at least a portion of a length of the coil from 
a proximal end toward a distal end thereof. 
8. The system of claim 1, wherein a radius of the coil is 
10 
substantially constant from a proximal end to a distal end of 
the coil. 
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13. The system of claim 1, wherein the outer lumen of the 
outer tube is configured for receiving a portion of the port 
when the one or more tabs are attached to the port. 
14. The system of claim 1, wherein the outer tube is con-
figured for rotating the attaching device via the one or more 
tabs to advance the coil at least partially through the tissue 
wall. 
15. The system of claim 1, further comprising a plug con-
figured for positioning at least partially within the opening of 
the port. 
16. The system of claim 15, wherein the plug is configured 
for releasably attaching to the port. 9. The system of claim 1, wherein the attaching device 
comprises a plurality of coils fixedly attached to the port and 
configured for advancing at least partially through the tissue 
wall such that at least a portion of each coil becomes disposed 
between the first surface and the second surface of the tissue 
wall. 
17. The system of claim 16, wherein the plug comprises 
15 threads configured for releasably engaging complementary 
threads of the port. 
10. The system of claim 9, wherein each of the coils is 
centered on the longitudinal axis of the attaching device. 
11. The system of claim 1, wherein the attaching device 20 
further comprises a flange extending about the port and con-
figured for engaging the tissue wall. 
12. The system of claim 1, wherein the one or more tabs are 
configured for releasably attaching to a proximal end of the 
port. 
18. The system of claim 15, wherein the plug comprises a 
second valve configured for controlling fluid flow through the 
plug and for permitting passage of instruments therethrough. 
19. The system of claim 18, wherein the second valve is 
formed by a flexibly sealable distal tip of the plug. 
20. The system of claim 15, wherein a distal tip of the plug 
is configured for extending at least partially through the tissue 
wall. 
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